In an interview in the New Scientist Magazine, principal investigator for the soon to begin Sangamo BioSciences (SGMO) stem cell HIV trial John Zaia states " The Goal is a Functional Cure".
John Zaia, M.D. is the Institutional Official for Research, City of Hope, Duarte CA.
It is great to hear him speak with such confidence.
The article also touches on the upcoming sickle cell trial:
"The trial blazes a path for using the approach to treat other diseases. For example, another trial set to start soon will focus on sickle cell disease, in which the oxygen-carrying haemoglobin molecules in red blood cells are abnormal. The technique would switch on a protein that can be used instead of the haemoglobin."
http://www.newscientist.com/article/mg22630194.200-human-gene-editing-has-arrived--heres-why-it-matters.html?full=true#.VUS-YZ0o7vZ
No comments:
Post a Comment